NewsSource: EClinCloud official website archive

EClinCloud Attends the 2025 Ningbo Biopharmaceutical Industry Development Conference

2 min readEClinCloud Editorial Team
Archived article cover: EClinCloud at the 2025 Ningbo Biopharmaceutical Industry Development Conference

On December 5–6, themed "Surging East China Sea, Pharma Shaping the Future: Ningbo Biopharmaceuticals Advancing Toward the 15th Five-Year Plan," the 4th China–Ningbo Biopharmaceutical Industry Development Conference was held in Ningbo Qianwan New Area. Organized by Hangzhou Bay Life Science Park (BioVillage), the conference was chaired by Zhao Yufen, Member of the Chinese Academy of Sciences and Dean of the Institute of New Drug Technology at Ningbo University, who delivered the opening remarks. The event featured 8 major tracks and attracted nearly 1,000 attendees.

 

As a key contributor in clinical-research digitalization, EClinCloud was invited to attend the conference and presented its digital and intelligent clinical-research achievements. At the conference's AI in Pharma/Healthcare session, Zhang Ji, Senior Product Consultant at EClinCloud, delivered a keynote presentation titled "Current Practical Applications of LLMs in Digital Clinical Trial Systems," sharing professional perspectives on the application of and innovative thinking around large language models (LLMs) in clinical research.

 

杭州湾生物医药谷临床研究AI主题分享  

 

 

From model capabilities to use-case value

Although AI faces numerous challenges at the clinical stage, it is rapidly expanding across every stage of new drug development—from trial participant recruitment and data management to endpoint assessment and efficacy prediction—and has the potential to reshape the overall efficiency and quality of clinical research.

In clinical research, algorithms, data, and computing power are the core elements of AI development, while aligning and implementing models, technologies, and use cases is the key to truly unlocking the value of AI.

 

 


临床研究AI应用的数据、安全与场景挑战

 

Examples of AI applications

In practice, current typical application outcomes of AI in EClinCloud's digital clinical systems include:

Document intelligence: AI-based automated form entry and intelligent archiving, enabling automated EDC study build and complex document parsing, among others;

Image intelligence: applied to intelligent eCOA QC, significantly improving data review accuracy;

Data intelligence: such as intelligent distribution anomaly detection and multivariate correlation analysis, supporting clinical data quality monitoring and insight optimization.

Through the integration of AI algorithms, computing power, and data, EClinCloud continues to build an integrated cloud platform covering the full clinical trial lifecycle, enabling intelligent collaboration from data capture to quality analysis and advancing high-quality clinical research.

At the conference, the EClinCloud booth drew broad interest from pharmaceutical companies, CROs, and research institutions, and the team held in-depth discussions with various partners on the practical implementation of AI in clinical research.

 

杭州湾生物医药谷活动中的一临云平台介绍  

Related reading

WeChat image 2026-11-11_150855_109.pngNews6 min readWorld COPD Day | Imaging Assessment in COPD Clinical ResearchNovember 13-15, 2026. November 18, 2026 marks the 25 World COPD Day, with this year's theme: Early Diagnosis and Management for a Better Life. Chronic Obstructive Pulmonary Disease (COPD) is a preventable and treatable disease characterized by persistent airflow limitation. COPD is closely related to chronic bronchitis and emphysema [1]. We have previously covered COAs for COPD,Article imageNews3 min readAddressing Complex Challenges in Clinical Research: EClinCloud’s Full-Lifecycle AI Enablement Attracts AttentionFrom November 13–15, the 2026 Nucleic Acid Therapy and Intelligent Biomedicine Industry Innovation Conference, academically guided by the Chinese Stroke Association and hosted by the Yuanshu Brain Science Research Center, was held in Fuzhou. Dr. Qin Long, founder and CEO of EClinCloud, was invited to deliver a keynote speech titled “Practice and Application of AI in Clinical Research,” sharing insights on the development trends of AI-enabled new drug R&D and the practice of AI throughout the clinical research process, which attracted enthusiastic attention from the attending guests. 01 Current Landscape of AI-Enabled New Drug R&D: AI is demonstrating application value in multiple segments of new drug R&D, including target discoverySAPA-China 2026 CNS Forum on-site photo 1News3 min readFocusing on CNS Clinical Endpoint Assessment: EClinCloud Shares eCOA and IRC PracticesAt the CNS Forum of the SAPA-China 2026 Pharmaceutical Industry Conference, Zheng Liangyan, Medical Director at EClinCloud, shared approaches to applying eCOA and IRC, covering challenges, regulatory requirements, and practical implementation in central nervous system (CNS) disease clinical research.